CVE-2020-27268

MEDIUMCVSS 6.5/10EPSS 0.54%

Last modified

CVE-2020-27268 is a medium-severity vulnerability rated 6.5/10 on the CVSS scale. In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass checks for default PINs via Bluetooth Low Energy.. EPSS estimates a 0.54% chance of exploitation in the next 30 days.

Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass checks for default PINs via Bluetooth Low Energy.

Metrics

CVSS 3.1
6.5/10

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

EPSS Probability
0.54%

41.2th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
SooilAnydana-A Firmware< 3.0
SooilAnydana-I Firmware< 3.0
SooilDiabecare Rs Firmware< 3.0

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2020-27268?
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass checks for default PINs via Bluetooth Low Energy.
How severe is CVE-2020-27268?
CVE-2020-27268 has a CVSS score of 6.5/10 (MEDIUM severity). The EPSS model estimates a 0.54% probability of exploitation in the next 30 days.
How do I fix CVE-2020-27268?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2020-27268?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST